Indiana Federal Judge Denies Dismissal In Generic Drug Dispute

(August 25, 2015, 1:38 PM EDT) -- INDIANAPOLIS — Efforts by two patent defendants to obtain dismissal of the allegations were denied Aug. 24 by an Indiana federal judge (Eli Lilly and Company, et al. v. Nang Kuang Pharmaceutical Co. Ltd., et al., No. 14-1647, S.D. Ind.; 2015 U.S. Dist. LEXIS 111510).

(Decision available. Document #16-150901-018Z.)

U.S. Judge Tanya Walton Pratt of the Southern District of Indiana found that Taiwan-based Nang Kuang Pharmaceutical Co. Ltd. and Texas-based CANDA NX-2 LLC “improperly focus” on the fact that the abbreviated new drug application (ANDA) in...
To view the full article, register now.